Table of Contents
Clinical Researches
| Interchangeability of Candesartan preparations in terms of Bioequivalence study | PDF (Русский) |
| I.A. Zupanets, N.P. Bezuglaya, V.Ye. Sabko, I.M. Khil | 11-14 |
| The Role of Autoimmune Reactivity in Arterial Hypertension of High Cardiovascular Risk | PDF (Русский) |
| V.A. Vizir, I.N. Voloshina | 15-19 |
| Dynamic of Anti-Hsp60 Antibodies in Moderate to Severe Arterial Hypertension | PDF (Українська) |
| L.F. Yakovenko, L.M. Kapustyan, Yu.V. Smalyuk, V.M. Granich, A.S. Dobrokhod, O.O. Torbas, G.D. Radchenko, G.F. Prymak, Yu.M. Sirenko, L.L. Sydoryk | 20-27 |
Postgraduate Education
| Antiatherogenic Effects of Angiotensin II Receptor Blocker Olmesartan: Mechanisms, Intensity and Clinical Significance | PDF (Українська) |
| S.M. Koval, L.A. Ryeznik, I.O. Snigurska, O.V. Mysnychenko | 28-34 |
To help clinicians
| Артериальная гипертензия у лиц пожилого возраста: возможности применения индапамида | PDF (Русский) |
| A.E. Bagriy | 39-42 |
Review
| Improvement in Quality of Life as Second Endpoint for Evaluation Antihypertensive Therapy Effectiveness | PDF (Українська) |
| I.M. Martsovenko, G.D. Radchenko, Yu.M. Sirenko, V.I. Martsovenko | 43-46 |
Clinical case
| Поликистоз почек в практике кардиолога: клинический случай | PDF (Русский) |
| A.D. Radchenko, Yu.N. Sirenko, Ye.A. Torbas, V.N. Granich | 49-56 |
